19p13.1 Is a triple-negative-specific breast cancer susceptibility locus

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3089255 62 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
19p13.1 Is a triple-negative-specific breast cancer susceptibility locus
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
The 19p13.1 breast cancer susceptibility locus is a modifier of breast cancer risk in BRCA1 mutation carriers and is also associated with the risk of ovarian cancer. Here, we investigated 19p13.1 variation and risk of breast cancer subtypes, defined by estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) status, using 48,869 breast cancer cases and 49,787 controls from the Breast Cancer Association Consortium (BCAC). Variants from 19p13.1 were not associated with breast cancer overall or with ER-positive breast cancer but were significantly associated with ER-negative breast cancer risk [rs8170 OR, 1.10; 95% confidence interval (CI), 1.05-1.15; P = 3.49 × 10-5] and triple-negative (ER-, PR-, and HER2-negative) breast cancer (rs8170: OR, 1.22; 95% CI, 1.13-1.31; P = 2.22 × 10-7). However, rs8170 was no longer associated with ERnegative breast cancer risk when triple-negative cases were excluded (OR, 0.98; 95% CI, 0.89-1.07; P = 0.62). In addition, a combined analysis of triple-negative cases from BCAC and the Triple Negative Breast Cancer Consortium (TNBCC; N = 3,566) identified a genome-wide significant association between rs8170 and triple-negative breast cancer risk (OR, 1.25; 95% CI, 1.18-1.33; P=3.31×10-13]. Thus, 19p13.1 is the first triple-negative- specific breast cancer risk locus and the first locus specific to a histologic subtype defined by ER, PR, and HER2 to be identified. These findings provide convincing evidence that genetic susceptibility to breast cancer varies by tumor subtype and that triple-negative tumors and other subtypes likely arise through distinct etiologic pathways. ©2012 AACR.
Έτος δημοσίευσης:
2012
Συγγραφείς:
Stevens, K.N.
Fredericksen, Z.
Vachon, C.M.
Wang, X.
Margolin, S.
Lindblom, A.
Nevanlinna, H.
Greco, D.
Aittomak̈i, K.
Blomqvist, C.
Chang-Claude, J.
Vrieling, A.
Flesch-Janys, D.
Sinn, H.-P.
Wang-Gohrke, S.
Nickels, S.
Brauch, H.
Ko, Y.-D.
Fischer, H.-P.
Schmutzler, R.K.
Meindl, A.
Bartram, C.R.
Schott, S.
Engel, C.
Godwin, A.K.
Weaver, J.
Pathak, H.B.
Sharma, P.
Brenner, H.
Mul̈ler, H.
Arndt, V.
Stegmaier, C.
Miron, P.
Yannoukakos, D.
Stavropoulou, A.
Fountzilas, G.
Gogas, H.J.
Swann, R.
Dwek, M.
Perkins, A.
Milne, R.L.
Benit́ez, J.
Zamora, M.P.
Peŕez, J.I.A.
Bojesen, S.E.
Nielsen, S.F.
Nordestgaard, B.G.
Flyger, H.
Gueńel, P.
Truong, T.
Menegaux, F.
Cordina-Duverger, E.
Burwinkel, B.
Marme, F.
Schneeweiss, A.
Sohn, C.
Sawyer, E.
Tomlinson, I.
Kerin, M.J.
Peto, J.
Johnson, N.
Fletcher, O.
Dos Santos Silva, I.
Fasching, P.A.
Beckmann, M.W.
Hartmann, A.
Ekici, A.B.
Lophatananon, A.
Muir, K.
Puttawibul, P.
Wiangnon, S.
Schmidt, M.K.
Broeks, A.
Braaf, L.M.
Rosenberg, E.H.
Hopper, J.L.
Apicella, C.
Park, D.J.
Southey, M.C.
Swerdlow, A.J.
Ashworth, A.
Nicholas, O.
Schoemaker, M.J.
Anton-Culver, H.
Ziogas, A.
Bernstein, L.
Dur, C.C.
Shen, C.-Y.
Yu, J.-C.
Hsu, H.-M.
Hsiung, C.-N.
Hamann, U.
Dun̈nebier, T.
Rud̈iger, T.
Ulmer, H.U.
Pharoah, P.P.
Dunning, A.M.
Humphreys, M.K.
Wang, Q.
Cox, A.
Cross, S.S.
Reed, M.W.
Hall, P.
Czene, K.
Ambrosone, C.B.
Ademuyiwa, F.
Hwang, H.
Eccles, D.M.
Garcia-Closas, M.
Figueroa, J.D.
Sherman, M.E.
Lissowska, J.
Devilee, P.
Seynaeve, C.
Tollenaar, R.A.E.M.
Hooning, M.J.
Andrulis, I.L.
Knight, J.A.
Glendon, G.
Mulligan, A.M.
Winqvist, R.
Pylkas̈, K.
Jukkola-Vuorinen, A.
Grip, M.
John, E.M.
Miron, A.
Alnsæ, G.G.
Kristensen, V.
Brøresen-Dale, A.-L.
Giles, G.G.
Baglietto, L.
McLean, C.A.
Severi, G.
Kosel, M.L.
Pankratz, V.S.
Slager, S.
Olson, J.E.
Radice, P.
Peterlongo, P.
Manoukian, S.
Barile, M.
Lambrechts, D.
Hatse, S.
Dieudonne, A.-S.
Christiaens, M.-R.
Chenevix-Trench, G.
Beesley, J.
Chen, X.
Mannermaa, A.
Kosma, V.-M.
Hartikainen, J.M.
Soini, Y.
Easton, D.F.
Couch, F.J.
Περιοδικό:
Current Cancer Research
Εκδότης:
American Association for Cancer Research Inc.
Τόμος:
72
Αριθμός / τεύχος:
7
Σελίδες:
1795-1803
Λέξεις-κλειδιά:
epidermal growth factor receptor 2; estrogen receptor; progesterone receptor, article; cancer risk; cancer susceptibility; chromosome 19p; chromosome identification; controlled study; female; gene locus; genetic association; genetic susceptibility; genetic variability; genotype; heterozygosity; histopathology; human; major clinical study; priority journal; single nucleotide polymorphism; triple negative breast cancer
Επίσημο URL (Εκδότης):
DOI:
10.1158/0008-5472.CAN-11-3364
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.